Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2020

Feb 4, 2020

29745_dirs_2020-02-04_26335041-4f7c-450a-8af5-aee72baff10b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2020-02-01

Reporting Person: Ricks David A (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-01 Common Stock M 69350 Acquired 226755 Direct
2020-02-01 Common Stock F 31089 $139.64 Disposed 195666 Direct
2020-01-31 Common Stock G 5000 Disposed 190666 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-01 Restricted Stock Unit $ M 69350 Disposed 2020-02-01 Common Stock (69350.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6563 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.